Manufacturer record
Proceed Formulations: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Proceed Formulations (Punjab) was declared Not of Standard Quality in August 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PFS-1204, Ofloxacin & Metronidazole Benzoate Suspension (VIVFLOX-MZ Suspension) (For Paediatric USE ONLY) (exp Oct 2024). CDTL Chennai (CDSCO lab) found it not of standard quality: ASSAY OF METRONIDAZOLE BENZOATE AND OFLOXACIN. Listed in the August 2023 alert.
Records by type
1 record linked to Proceed Formulations in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin & Metronidazole Benzoate Suspension (VIVFLOX-MZ Suspension) (For Paediatric USE ONLY) | Batch PFS-1204Mfg Nov 2022 · Exp Oct 2024 | ASSAY OF METRONIDAZOLE BENZOATE AND OFLOXACINAssay | CDTL ChennaiCDSCO lab | Aug 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.